Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2025
DOI: 10.6004/jnccn.2025.0037 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025. Verfasst von Frank Balis und 31 weiteren Autor:innen. Beteiligte Einrichtung: 1Abramson Cancer Center at the University of Pennsylvania. Hauptthemen laut MEDLINE: Wilms Tumor, Kidney Neoplasms, Medical Oncology. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 122 Literaturangaben.
Abstract (Originalsprache)
The NCCN Clinical Practice Guidelines (NCCN Guidelines) for Wilms Tumor (WT; nephroblastoma) cover strategies for the screening, diagnosis, and treatment of WT, which is the most frequent primary kidney tumor in children. WT can generally be separated into 2 histology types: favorable histology WT and anaplastic WT. Five-year survival is high for children with favorable histology WT who receive appropriate treatment; however, survival rates are much lower for patients who present with higher stage diffuse anaplastic WT. Treatment of WT can range from surgery alone to surgery plus intensive chemotherapy and radiation depending on whether the tumor is unilateral or bilateral, histology, and local stage. The goal of therapy is to maximize cure while minimizing long-term toxicities. The content featured in this issue covers the NCCN panel’s recommendations for overall management of both favorable histology WT and anaplastic WT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Abramson Cancer Center at the University of Pennsylvania.
- 2St. Jude Children's Research Hospital/ The University of Tennessee Health Science Center.
- 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
- 4O'Neal Comprehensive Cancer Center at UAB.
- 5Vanderbilt-Ingram Cancer Center.
- 6The University of Texas MD Anderson Cancer Center.
Zitieren
APA
Balis, F., Green, D. M., Armstrong, A., Aye, J., Benedetti, D., Brown, B., Brown, E., Cook, S., Desai, A., Dhillon, J., Fair, D., Geynisman, D. M., Hiniker, S., Horst, K., Jasty-Rao, R., Just, M., Kieran, K., Lin, C., MacEwan, I., …, & Sliker, B. (2025). Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.0037
Vancouver
Balis F, Green DM, Armstrong A, Aye J, Benedetti D, Brown B, et al. Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2025. doi:10.6004/jnccn.2025.0037
BibTeX
@article{Balis2025,
author = {Balis, Frank and Green, Daniel M and Armstrong, Amy and Aye, Jamie and Benedetti, Daniel and Brown, Brandon and Brown, Erin and Cook, Shelly and Desai, Ami and Dhillon, Jasreman and Fair, Douglas and Geynisman, Daniel M and Hiniker, Susan and Horst, Kelly and Jasty-Rao, Rama and Just, Marissa and Kieran, Kathleen and Lin, Chi and MacEwan, Iain and Martinez-Agosto, Julian and Mullen, Elizabeth and Murphy, Erin S and Pinto, Navin and Ranalli, Mark and Rhee, Daniel and Rokitka, Denise and Walz, Amy and Wickiser, Jonathan and Yoon, Janet and Zapala, Matthew and Montgomery, Sarah and Sliker, Bailee},
title = {Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
doi = {10.6004/jnccn.2025.0037}
}
EUVIMED